This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Decision Resources Inc.Wyeth/Amgen's Enbrel to Achieve Blockbuster Status by 2010 for the Treatment of Psoriasis. Media Release: 11 Sep 2006. Available from: URL: http://www.decisionresources.com
Decision Resources Inc.Drugs from Bayer/Johnson & Johnson and Boehringer Ingelheim Have Blockbuster Potential in the Atrial Fibrillation Market. Media Release: 5 Sep 2006. Available from: URL: http://www.decisionresources.com
Rights and permissions
About this article
Cite this article
Blockbuster forecasts in psoriasis, AF markets. Pharmacoecon. Outcomes News 512, 10 (2006). https://doi.org/10.2165/00151234-200605120-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605120-00026